Jobs
-
Powder characterization specialist Freeman Technology has announced that its Chinese operations have moved into a larger facility equipped with a laboratory and that the company has hired Tom Qin as General Manager and Ruty Li… Read more . . .
-
Mast Therapeutics has announced that the Duke Clinical Research Institute will serve as the coordinating center for the Heart Failure Clinical Research Network (HFN) as it conducts a Phase 2 study of AIR001 sodium nitrite… Read more . . .
-
Quotient Clinical’s new GMP facility in Nottingham, UK will include added spray drying capacity for spray drying of batches up to 2 kilograms. The facility is scheduled to open later this year. Quotient Clinical’s inhaled… Read more . . .
-
Hovione has announced the launch of a new company called Hovione Technology, which “focuses on offering an inhaler that matches your product, your needs, your patients.” The company’s devices include the Twin Caps and PowdAir… Read more . . .
-
Raptor Pharmaceutical has launched Quinsair levofloxacin inhalation solution for the treatment of P. aeruginosa infections in cystic fibrosis patients in Germany and Denmark, the company said. According to Raptor, it plans to launch Quinsair in… Read more . . .
-
An analysis of data from Boehringer Ingelheim’s WISDOM study showed that withdrawal of ICS for COPD patients using the Spiriva Handihaler tiotropium bromide DPI plus salmeterol is associated with a higher exacerbation rate in patients… Read more . . .
-
In a leading article published in the Archives of Disease in Childhood, Andrew Bush and Louise Fleming of Royal Brompton Hospital and the National Heart and Lung Institute, Imperial College London assert that “the diagnosis… Read more . . .
-
InCarda Therapeutics, which is developing an inhaled treatment for paroxysmal atrial fibrillation, has appointed former Gilead Senior VP for Cardiovascular Therapeutics Luiz Belardinelli as Chief Medical Officer, the company said. Belardinelli will continue as a… Read more . . .
-
Cohero Health and H&T Presspart have announced the availability of a new connected metered dose inhaler (eMDI). The eMDI collects actuation data from an integral sensor and transmits the data via Bluetooth to Cohero Health’s… Read more . . .
-
Chiesi has reported a greater than 9% increase in revenue from 2014 to 2015, with an almost 20% increase in sales of Foster (Fostair) beclamethasone/formoterol inhalers and an unspecified increase in sales of Clenil beclamethasone… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland